Imperial College London

ProfessorJustinMason

Faculty of MedicineNational Heart & Lung Institute

Head of Section for Vascular Science
 
 
 
//

Contact

 

justin.mason Website

 
 
//

Assistant

 

Ms Grace Ma +44 (0)20 7594 6457

 
//

Location

 

L Block 537Hammersmith HospitalHammersmith Campus

//

Summary

 

Summary

Justin Mason is Professor of Vascular Rheumatology within Vascular Sciences, National Heart and Lung Institute at  Hammersmith Hospital.

Professor Mason leads a basic science research group investigating molecular mechanisms involved in the regulation of vascular endothelial cytoprotection. A more detailed understanding of these mechanisms will facilitate the rational design of novel therapies by which vascular endothelium can be conditioned in order to minimise vascular injury, EC dysfunction and subsequent atherogenesis in patients with systemic inflammatory disease. In addition, he is actively involved in clinical research, which aims to optimise clinical assessment and treatment of the large vessel vasculitides and understand the relationship between chronic endothelial dysfunction and accelerated atherosclerosis. Read more on Justin's research.

Justin graduated in Medicine in 1986 from the University of London and trained in Rheumatology at the Kennedy Institute of Rheumatology, Charing Cross Hospital and at the Royal Postgraduate Medical School in London. Following award of a Medical Research Council Training Fellowship in 1992 and subsequently a PhD degree in 1996 from Imperial College London, he was awarded an Arthritis Research Campaign Senior Research Fellowship in 2000. He is a Fellow of the Royal College of Physicians in London and of the Association of Physicians of Great Britain and Ireland, and is the Chair of the Arthritis Research UK - Research Education and Capacity Committee, a member of the Medical Research Society Committee and the British Heart Foundation Project Grant Committee..


Publications

Journals

Dufton NP, peghaire CR, Osuna-Almagro L, et al., Dynamic regulation of canonical TGFβ signaling by endothelial transcription factor ERG protects from liver fibrogenesis, Nature Communications, ISSN:2041-1723

Youngstein T, Tombetti E, Mukherjee J, et al., 18F-FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease: results from a cohort study, Jacc: Cardiovascular Imaging, ISSN:1876-7591

Bechman K, Gopalan D, Nihoyannopoulos P, et al., 2017, A cohort study reveals myocarditis to be a rare and life-threatening presentation of large vessel vasculitis., Semin Arthritis Rheum, Vol:47, Pages:241-246

Dejaco C, Brouwer E, Mason JC, et al., 2017, Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities, Nature Reviews Rheumatology, Vol:13, ISSN:1759-4790, Pages:578-592

Incerti E, Tombetti E, Fallanca F, et al., 2017, F-18-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis, European Journal of Nuclear Medicine and Molecular Imaging, Vol:44, ISSN:1619-7070, Pages:1109-1118

More Publications